echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Notice on Public Solicitation of "Guiding Principles for Pharmaceutical Research of Traditional Chinese Medicine Compound Preparations Managed in the Catalogue of Ancient Classic Famous Prescriptions (Draft for Solicitation of Comments)"

    Notice on Public Solicitation of "Guiding Principles for Pharmaceutical Research of Traditional Chinese Medicine Compound Preparations Managed in the Catalogue of Ancient Classic Famous Prescriptions (Draft for Solicitation of Comments)"

    • Last Update: 2021-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com





    In order to promote the inheritance and innovation of traditional Chinese medicine, guide the rational development of the pharmaceutical research of traditional Chinese medicine compound preparations managed according to the catalogue of ancient classic famous prescriptions, and promote the research and development and registration of Chinese medicine compound preparations managed according to the catalogue of ancient classic famous prescriptions, the Center for Drug Evaluation has drafted "Guiding Principles for Pharmaceutical Research of Chinese Medicine Compound Preparations for the Management of Ancient Classic Famous Prescriptions Catalogue (Draft for Solicitation of Comments)".


    After soliciting opinions from all relevant majors within the center and some R&D units, a draft for soliciting opinions was formed.
    Now the center website is publicized to listen to opinions and suggestions from all walks of life.


    We sincerely welcome valuable comments and suggestions from all walks of life on the solicitation draft, and timely feedback to us for follow-up improvement.


    The time limit for soliciting opinions is one month from the date of publication.


    Please send your feedback to the mailbox: zyyxzdyz@cde.


    Thank you for your participation and great support.


    Drug Evaluation Center of the State Drug Administration

    April 26, 2021



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.